Scientific, statistical, practical, and regulatory considerations in design space development

Abstract The quality by design (QbD) paradigm guides the pharmaceutical industry towards improved understanding of products and processes, and at the same time facilitates a high degree of manufacturing and regulatory flexibility throughout the establishment of the design space. This review article presents scientific, statistical and regulatory considerations in design space development. All key development milestones, starting with planning, selection of factors, experimental execution, data analysis, model development and assessment, verification, and validation, and ending with design space submission, are presented and discussed. The focus is especially on frequently ignored topics, like management of factors and CQAs that will not be included in experimental design, evaluation of risk of failure on design space edges, or modeling scale-up strategy. Moreover, development of a design space that is independent of manufacturing scale is proposed as the preferred approach.

[1]  C. M. Moore,et al.  Scientific and Regulatory Considerations for Implementing Mathematical Models in the Quality by Design (QbD) Framework , 2014 .

[2]  Emad B. Basalious,et al.  Application of Pharmaceutical QbD for Enhancement of the Solubility and Dissolution of a Class II BCS Drug using Polymeric Surfactants and Crystallization Inhibitors: Development of Controlled-Release Tablets , 2011, AAPS PharmSciTech.

[3]  D. Ende,et al.  Chemical engineering in the pharmaceutical industry : R&D to manufacturing , 2010 .

[4]  Craig A. Mckelvey,et al.  ACHIEVING A HOT MELT EXTRUSION DESIGN SPACE FOR THE PRODUCTION OF SOLID SOLUTIONS , 2010, Chemical Engineering in the Pharmaceutical Industry.

[5]  T. De Beer,et al.  Optimization of a pharmaceutical freeze-dried product and its process using an experimental design approach and innovative process analyzers. , 2011, Talanta.

[6]  Roger Nosal,et al.  API Quality by Design Example from the Torcetrapib Manufacturing Process , 2007, Journal of Pharmaceutical Innovation.

[7]  Jianping Liu,et al.  A quality by design (QbD) case study on enteric- coated pellets: Screening of critical variables and establishment of design space at laboratory scale , 2014 .

[8]  Johan A. Westerhuis,et al.  Multivariate modelling of the tablet manufacturing process with wet granulation for tablet optimization and in-process control , 1997 .

[9]  John Lepore,et al.  PQLI Design Space , 2008, Journal of Pharmaceutical Innovation.

[10]  Sajal Manubhai Patel,et al.  Lyophilization process design space. , 2013, Journal of pharmaceutical sciences.

[11]  Shingo Kikuchi,et al.  Reliability evaluation of nonlinear design space in pharmaceutical product development. , 2012, Journal of pharmaceutical sciences.

[12]  Pedro Hernandez-Abad,et al.  Quality by design case study: an integrated multivariate approach to drug product and process development. , 2009, International journal of pharmaceutics.

[13]  Jérôme Mantanus,et al.  Optimization of a pharmaceutical tablet formulation based on a design space approach and using vibrational spectroscopy as PAT tool. , 2015, International journal of pharmaceutics.

[14]  Mario Schmidt,et al.  The Sankey Diagram in Energy and Material Flow Management , 2008 .

[15]  I. Ilič,et al.  In silico modeling of in situ fluidized bed melt granulation. , 2014, International journal of pharmaceutics.

[16]  Aili Cheng,et al.  Finding Design Space and a Reliable Operating Region Using a Multivariate Bayesian Approach with Experimental Design , 2009 .

[17]  Douglas C. Montgomery,et al.  Response Surface Methodology: Process and Product Optimization Using Designed Experiments , 1995 .

[18]  Najiah Nadir,et al.  Improvement of one factor at a time through design of experiments , 2012 .

[19]  Alan D. Braem,et al.  An Example of Utilizing Mechanistic and Empirical Modeling in Quality by Design , 2010, Journal of Pharmaceutical Innovation.

[20]  K. Kristan,et al.  Rapid exploration of curing process design space for production of controlled-release pellets. , 2012, Journal of pharmaceutical sciences.

[21]  Josep Ramon Ticó,et al.  Approach to design space from retrospective quality data , 2016, Pharmaceutical development and technology.

[22]  Naseem A. Charoo,et al.  Quality by design approach for formulation development: a case study of dispersible tablets. , 2012, International journal of pharmaceutics.

[23]  J. I.  The Design of Experiments , 1936, Nature.

[24]  Theodora Kourti,et al.  Pharmaceutical Manufacturing: The Role of Multivariate Analysis in Design Space, Control Strategy, Process Understanding, Troubleshooting, and Optimization , 2010 .

[25]  Melody Trexler-Schmidt,et al.  Process characterization and Design Space definition. , 2016, Biologicals : journal of the International Association of Biological Standardization.

[26]  Jérôme Mantanus,et al.  Design space approach in the optimization of the spray-drying process. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[27]  Vivek S. Dave,et al.  Excipient variability and its impact on dosage form functionality. , 2015, Journal of pharmaceutical sciences.

[28]  D. Hatziavramidis,et al.  Dissolution Efficiency and Design Space for an Oral Pharmaceutical Product in Tablet Form , 2015 .

[29]  M. Bezerra,et al.  Response surface methodology (RSM) as a tool for optimization in analytical chemistry. , 2008, Talanta.

[30]  Davide Fissore,et al.  Advanced approach to build the design space for the primary drying of a pharmaceutical freeze-drying process. , 2011, Journal of pharmaceutical sciences.

[31]  André I. Khuri,et al.  Response surface methodology , 2010 .

[32]  Davide Fissore,et al.  Quality by design: optimization of a freeze-drying cycle via design space in case of heterogeneous drying behavior and influence of the freezing protocol , 2013, Pharmaceutical development and technology.

[33]  Manish Gupta,et al.  Application of Multivariate Tools in Pharmaceutical Product Development to Bridge Risk Assessment to Continuous Verification in a Quality by Design Environment , 2010, Journal of Pharmaceutical Innovation.

[34]  Xiangyang Wang,et al.  Defining Process Design Space for Biotech Products: Case Study of Pichia pastoris Fermentation , 2008, Biotechnology progress.

[35]  Rui Oliveira,et al.  Hybrid modeling as a QbD/PAT tool in process development: an industrial E. coli case study , 2016, Bioprocess and Biosystems Engineering.

[36]  Alan D. Braem,et al.  Model-Guided Design Space Development for a Drug Substance Manufacturing Process , 2011, Journal of Pharmaceutical Innovation.

[37]  Koji Muteki,et al.  De-risking Pharmaceutical Tablet Manufacture Through Process Understanding, Latent Variable Modeling, and Optimization Technologies , 2011, AAPS PharmSciTech.

[38]  H. Wu,et al.  Quality-by-Design (QbD): An integrated process analytical technology (PAT) approach for a dynamic pharmaceutical co-precipitation process characterization and process design space development. , 2011, International journal of pharmaceutics.

[39]  P. Hubert,et al.  Implementation of a design space approach for enantiomeric separations in polar organic solvent chromatography. , 2013, Journal of pharmaceutical and biomedical analysis.

[40]  Peter York,et al.  Establishing and analyzing the design space in the development of direct compression formulations by gene expression programming. , 2012, International journal of pharmaceutics.

[41]  Ingmar Nopens,et al.  Uncertainty analysis as essential step in the establishment of the dynamic Design Space of primary drying during freeze-drying. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[42]  J. G. Rosas,et al.  Quality by design approach of a pharmaceutical gel manufacturing process, part 1: determination of the design space. , 2011, Journal of pharmaceutical sciences.

[43]  Graham McCreath,et al.  Practical Considerations for DoE Implementation in Quality By Design , 2010 .

[44]  Rui Oliveira,et al.  Hybrid modeling for quality by design and PAT-benefits and challenges of applications in biopharmaceutical industry. , 2014, Biotechnology journal.

[45]  K. Leiviskä,et al.  Influence of granulation and compression process variables on flow rate of granules and on tablet properties, with special reference to weight variation , 1994 .

[46]  James K. Drennen,et al.  Innovation in Pharmaceutical Experimentation Part 1: Review of Experimental Designs Used in Industrial Pharmaceutics Research and Introduction to Bayesian D-Optimal Experimental Design , 2008, Journal of Pharmaceutical Innovation.

[47]  Johannes G Khinast,et al.  An integrated Quality by Design (QbD) approach towards design space definition of a blending unit operation by Discrete Element Method (DEM) simulation. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[48]  H. Goshima,et al.  Impact of Ice Morphology on Design Space of Pharmaceutical Freeze-Drying. , 2016, Journal of pharmaceutical sciences.

[49]  Davide Fissore,et al.  On the use of mathematical models to build the design space for the primary drying phase of a pharmaceutical lyophilization process. , 2011, Journal of pharmaceutical sciences.

[50]  Roger Nosal,et al.  PQLI Key Topics - Criticality, Design Space, and Control Strategy , 2008, Journal of Pharmaceutical Innovation.

[51]  Hervé Broly,et al.  Application of the quality by design approach to the drug substance manufacturing process of an Fc fusion protein: towards a global multi-step design space. , 2012, Journal of pharmaceutical sciences.

[52]  G. K. Raju,et al.  Understanding Pharmaceutical Quality by Design , 2014, The AAPS Journal.

[53]  Marco Cavazzuti,et al.  Optimization Methods: From Theory to Design Scientific and Technological Aspects in Mechanics , 2012 .

[54]  Jukka Rantanen,et al.  Quality by design approach in the optimization of the spray-drying process , 2012, Pharmaceutical development and technology.

[55]  J. Parojčić,et al.  An investigation into the usefulness of different empirical modeling techniques for better control of spray-on fluidized bed melt granulation. , 2015, International journal of pharmaceutics.

[56]  Marco Cavazzuti,et al.  Design of Experiments , 2013 .

[57]  Carlo Castagnoli,et al.  Application of Quality by Design Principles for the Definition of a Robust Crystallization Process for Casopitant Mesylate , 2010 .

[58]  Nils-Olof Lindberg,et al.  Multivariate methods in pharmaceutical applications , 2002 .

[59]  Veronica Czitrom,et al.  One-Factor-at-a-Time versus Designed Experiments , 1999 .

[60]  Naseem A. Charoo,et al.  Quality risk management in pharmaceutical development , 2013, Drug development and industrial pharmacy.

[61]  Dimitris Hatziavramidis,et al.  Design Space Approach for Pharmaceutical Tablet Development , 2014 .

[62]  Tamás Sovány,et al.  Estimation of design space for an extrusion-spheronization process using response surface methodology and artificial neural network modelling. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[63]  John J. Peterson,et al.  The ICH Q8 Definition of Design Space: A Comparison of the Overlapping Means and the Bayesian Predictive Approaches , 2010 .

[64]  Sumit Luthra,et al.  Investigation of Design Space for Freeze-Drying: Use of Modeling for Primary Drying Segment of a Freeze-Drying Cycle , 2011, AAPS PharmSciTech.

[65]  William F. Kiesman,et al.  Case Studies in the Applicability of Drug Substance Design Spaces Developed on the Laboratory Scale to Commercial Manufacturing , 2015 .

[66]  J. Trygg,et al.  Design Space Estimation of the Roller Compaction Process , 2013 .

[67]  Dennis Jenke,et al.  Application of Quality by Design (QbD) Principles to Extractables/Leachables Assessment. Establishing a Design Space for Terminally Sterilized Aqueous Drug Products Stored in a Plastic Packaging System. , 2010, PDA journal of pharmaceutical science and technology.